Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma

Blood

Volumn 124, Issue 12, 2014, Pages 2001-2003

  Erickson, Stephen W ^a   Raj, Vinay R ^a   Stephens, Owen W ^a   Dhakal, Ishwori ^a   Chavan, Shweta S ^a   Sanathkumar, Naveen ^a   Coleman, Elizabeth Ann ^a   Lee, Jeannette Y ^a   Goodwin, Julia A ^a   Apewokin, Senu ^a   Zhou, Daohong ^a   Epstein, Joshua ^a   Heuck, Christoph J ^a   Vangsted, Annette J ^b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Rigshospitalet   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

ADULT; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DRUG MEGADOSE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PATIENT RISK; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHROMOSOME 2; GENETICS; RISK FACTOR;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 2; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE MYELOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84907222567     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-07-586701     Document Type: Letter

References (10)

1. Li C, Zhao H, Hu Z, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat. 2008;29(12):1443-1451.
2. Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99(5): 1745-1757.
3. Groux-Degroote S, Krzewinski-Recchi M-A, Cazet A, et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem J. 2008;410(1):213-223.
4. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2013;328(2): 198-206.
5. Park GB, Kim YS, Kim D, et al. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA. J Immunol. 2013;191(12):6281-6291.
6. Vogel U, Overvad K, Wallin H, Tjønneland A, Nexø BA, Raaschou-Nielsen O. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett. 2005;222(1):67-74.
7. Hansen RD, Sørensen M, Tjønneland A, et al. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res. 2007;619(1-2):68-80.
8. Broderick P, Chubb D, Johnson DC, et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet. 2012; 44(1):58-61.
9. Chubb D, Weinhold N, Broderick P, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013; 45(10):1221-1225.
10. Martino A, Buda G, Maggini V, et al. Could age modify the effect of genetic variants in IL6 and TNF-a genes in multiple myeloma? Leuk Res. 2012;36(5): 594-597.